Active Ingredient(s): Crisaborole
FDA Approved: * December 14, 2016
Pharm Company: * ANACOR PHARMS INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Eucrisa Overview

Crisaborole (INN,[1] USAN, trade name Eucrisa ew-KRIS-, codenamed AN2728) is a non-steroidal, topical medication approved for the treatment of mild-to-moderate atopic dermatitis (eczema) in patients 2 years of age and older.[2][3] As of 2016[update] it is also under development by Anacor Pharmaceuticals for the topical treatment of psoriasis.[4][5][6][7] Contents 1 Mechanism of action 2 Clinical trials 3 See also 4 References Mechanism of action It is a phosphodiesterase-4 inhibit...

Read more Eucrisa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Eucrisa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Ointment: 2%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Eucrisa: (1 result)

Sorted by National Drug Code
  • 55724-211 Eucrisa 20 mg/g Topical Ointment by Anacor Pharmaceuticals, Inc.

Other drugs which contain Crisaborole or a similar ingredient: (1 result)